Contraception
Volume 79, Issue 4 , Pages 259-271 , April 2009

Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy — a systematic review

  • Rodolfo Gómez Ponce de León

      Affiliations

    • IPAS and School of Public Health, University of North Carolina at Chapel Hill, NC 28516, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 919 9605573; fax: +1 919 9297687.
    • ,
  • Deborah A. Wing

      Affiliations

    • Division of Maternal–Fetal Medicine, Department of Obstetrics–Gynecology, University of California, Irvine, CA 92868, USA

Received 17 July 2008 ,Revised 13 October 2008 ,Accepted 15 October 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ No financial support was received for this report.

☆☆ Dr. Wing is a principal investigator for Cytokine PharmaSciences, developer of a time-released misoprostol vaginal insert.

PII: S0010-7824(08)00490-3

doi: 10.1016/j.contraception.2008.10.009

Contraception
Volume 79, Issue 4 , Pages 259-271 , April 2009

Article Tools

* Image Usage & Resolution